The final assessment of the Epithrive® MR Training Programme. Successful completion certifies you as an Epithrive® Certified Product Expert, authorised for solo field deployment.
Which cell type is the primary consumer of L-Glutamine in wound healing, and is responsible for killing bacteria through phagocytosis in the first 48 hours?
A
Fibroblasts — the primary collagen-producing cells
B
Keratinocytes — the epithelial cells that resurface the wound
C
Neutrophils — immune cells arriving within hours that phagocytose bacteria
D
Platelets — the first responders that form the initial clot
4
Which enzyme system, when chronically overactivated in the chronic wound microenvironment, destroys the extracellular matrix faster than fibroblasts can rebuild it — trapping the wound in a persistent stall?
A
Lysyl oxidase — responsible for collagen cross-linking
DNA polymerase — required for cell division in proliferating cells
D
Glutathione peroxidase — the antioxidant protection enzyme
5
Approximately what percentage of Indian surgical and elderly hospital patients are estimated to be nutritionally deficient or malnourished at the time of hospital admission?
A
10–15%
B
20–25%
C
30–50%
D
60–75%
6
In wound healing biology, angiogenesis — the growth of new blood vessels into the wound bed — is primarily driven by which Epithrive® ingredient through nitric oxide production?
A
Marine Collagen Peptides (2.5g)
B
L-Arginine (7g) → Nitric Oxide via NOS pathway
C
Ca-HMB (1.5g) via mTOR pathway activation
D
Zinc (13mg) as cofactor for endothelial cell DNA polymerase
🩹
Section 2
Wound Care Fundamentals
Questions 7–11 · 5 marks
7
In the T.I.M.E. wound management framework, what does the letter "E" specifically represent?
A
Exudate control — managing wound fluid volume
B
Enzymatic debridement of non-viable tissue
C
Epithelial/Edge advancement — stimulating wound closure through keratinocyte migration
D
Elevation — offloading pressure from the wound site
8
Silver antimicrobial dressings are typically used for a limited duration (2–4 weeks) and not indefinitely. What is the primary clinical reason for this restriction?
A
Bacteria develop silver resistance after 2 weeks, making them ineffective
B
Silver ions are cytotoxic to fibroblasts at high concentrations with prolonged exposure, impeding granulation
C
Silver dressings are too expensive for prolonged outpatient use
D
Silver dressings cause wound maceration when used beyond 2 weeks
9
Which global guidelines body explicitly recommends Arginine, Zinc, and Vitamin C supplementation specifically for pressure injury patients?
A
FSSAI — Food Safety and Standards Authority of India
B
WHO — World Health Organization Nutrition Division
CDSCO — Central Drugs Standard Control Organisation
10
In a Wagner Grade II diabetic foot ulcer, the wound extends to which tissue depth?
A
Superficial ulcer — epidermis only, no tissue involvement
B
Deep ulcer penetrating to tendon, capsule, or bone without abscess
C
Deep abscess with osteomyelitis
D
Partial gangrene of the foot
11
Negative Pressure Wound Therapy (NPWT / VAC therapy) is a particularly strong indication for initiating Epithrive® alongside it because:
A
NPWT depletes amino acids directly from the wound, which Epithrive® replenishes
B
NPWT mechanically drives granulation but demands Arginine, Glutamine, and Collagen substrates to build it — creating the highest nutritional demand of any dressing modality
Ca-HMB (Calcium β-Hydroxy-β-Methylbutyrate) is included in the Epithrive® India formulation to address which specific clinical problem in wound patients?
A
Collagen fibre instability due to insufficient cross-linking in the remodeling phase
B
Immune cell depletion causing susceptibility to wound infection
C
Muscle protein catabolism — chronic wounds trigger the ubiquitin-proteasome breakdown pathway, and HMB specifically inhibits this
D
Nitric oxide deficiency causing impaired endothelial blood flow to the wound
14
Marine Collagen Peptides in Epithrive® are absorbed from the gut in which form, reaching peak plasma concentration within approximately 1 hour?
A
As individual amino acids (glycine, proline) after complete hydrolysis in the intestine
B
As intact dipeptides and tripeptides (e.g. Gly-Pro-Hyp) via the PEPT1 transporter
C
As large collagen molecules that are broken down by hepatic enzymes before distribution
D
As hydroxyproline-only fragments after gastric acid digestion
15
Without Copper (1.3mg per sachet), newly formed collagen fibres cannot be properly cross-linked. Which enzyme does Copper enable, and what is the clinical consequence of its absence?
A
DNA polymerase — consequence: cell division in fibroblasts stops
B
Lysyl oxidase — consequence: collagen fibres are laid down but structurally weak, causing wound dehiscence risk
Prolyl hydroxylase — consequence: collagen triple helix cannot be stabilised
16
Vitamin C (60mg per sachet) is described as the "rate-limiting cofactor" for collagen synthesis. What specifically does it enable that no other ingredient in the formulation can substitute?
A
It fuels fibroblast energy metabolism via the Krebs cycle as an intermediate substrate
B
It enables hydroxylation of proline and lysine residues by prolyl/lysyl hydroxylase — stabilising the collagen triple helix
C
It activates the MMP-inhibiting cascade that prevents collagen degradation in chronic wounds
D
It cross-links mature collagen fibres via a ceruloplasmin-dependent pathway
17
Vitamin A (750mcg per sachet) specifically supports which wound healing process that Vitamin C does not address?
A
Collagen triple helix stabilisation via hydroxylation of proline residues
B
Re-epithelialization — driving keratinocyte differentiation and migration across the wound surface via retinoic acid signalling
C
Macrophage phagocytosis via interleukin-6 pathway activation
D
Angiogenesis via nitric oxide-mediated endothelial activation
18
A patient on ciprofloxacin for wound infection is starting Epithrive®. What is the correct administration guidance and why?
A
Take simultaneously — there are no clinically significant interactions between amino acids and fluoroquinolone antibiotics
B
Space by at least 2–3 hours — Zinc in Epithrive® chelates quinolone antibiotics, reducing absorption of both if taken simultaneously
C
Wait until the antibiotic course is complete, then start Epithrive®
D
Space by 30 minutes — Arginine reduces ciprofloxacin efficacy at the NOS binding site
19
In the global formulation of Epithrive® (USA, UAE, Europe), Ca-HMB is replaced with which combination — and what is the clinical rationale for this specific replacement?
A
L-Leucine (3g) — to provide the same anti-catabolic signal via the same Leucine metabolite pathway
B
L-Citrulline (1.5g) + L-Ornithine (1.5g) — to maintain the nitric oxide pathway without Arginine
C
L-Proline (1.5g) + L-Lysine (1.5g) — to avoid Abbott Juven patent infringement, creating a complete collagen synthesis complex
D
Creatine monohydrate (1.5g) + Beta-alanine (1.5g) — to provide anti-fatigue and muscle support
20
Selenium (30mcg per sachet) functions as a cofactor for which specific enzyme system that provides antioxidant protection in healing tissue?
A
Lysyl oxidase — the collagen cross-linking enzyme
B
Prolyl hydroxylase — the collagen stabilising enzyme
C
Glutathione peroxidase (GPx) — the body's primary enzyme-based antioxidant system, neutralising hydrogen peroxide and lipid peroxides
Zinc (13mg per sachet) serves which specific critical function in the remodeling phase of wound healing — beyond its role in epithelialization?
A
Fuelling macrophage phagocytosis through energy metabolism
B
Regulating matrix metalloproteinase (MMP) activity — ensuring balanced ECM breakdown and rebuilding for scar maturation
C
Cross-linking collagen fibres via the lysyl oxidase cofactor pathway
D
Activating the mTOR pathway to preserve lean muscle mass
📊
Section 4
Clinical Evidence
Questions 22–28 · 7 marks
22
What was the precise primary finding of the Epithrive® Indian clinical study (CSR-ETH-2025-001) at Week 8?
A
65.0% (Epithrive® arm) vs 48.0% (control) wound area reduction — p=0.01
B
72.4% (Epithrive® arm) vs 52.1% (control) wound area reduction — p=0.004
C
72.4% (Epithrive® arm) vs 52.1% (control) wound area reduction — p=0.04
D
80.2% (Epithrive® arm) vs 52.1% (control) wound area reduction — p=0.004
23
The India study showed a p-value of 0.004. When explaining this to a skeptical doctor, the most accurate interpretation is:
A
There is a 4% probability the result occurred by chance — acceptable but moderate confidence
B
There is a 0.4% probability the result occurred by chance — we are 99.6% confident the difference is real
C
The study was 0.4% underpowered relative to an ideal sample size
D
The effect size was 0.4% above the minimum clinically important difference
24
Williams and Barbul (2002, Annals of Surgery) published which specific finding that is directly relevant to Epithrive®'s surgical wound patient indication?
A
Glutamine supplementation reduced ICU infections by 45% in critically ill patients (Wischmeyer 2003)
B
Arg+Gln+HMB blend reduced DFU healing time from 247 days to 83 days (Tatti 2012)
C
Arginine+HMB+Glutamine significantly increased wound collagen deposition in a double-blind RCT in elderly volunteers, with 3.5-day reduction in hospital stay
D
Arginine-enriched formula produced 19% greater wound area reduction vs standard ONS in pressure ulcer patients (Cereda 2015)
25
A knowledgeable diabetologist raises the Armstrong et al. (2014) RCT, which showed no significant primary outcome difference with the Arg+Gln+HMB formulation class in DFU patients. The correct and complete response is:
A
That study used an older formulation version — Epithrive®'s India data supersedes it
B
The primary outcome (overall DFU population at 16 weeks) was negative, but subgroup analysis showed benefit in malnourished patients (low albumin, poor perfusion) — which is exactly Epithrive®'s target patient profile
C
Armstrong's study was not randomised and should not be cited by doctors
D
Armstrong 2014 used a different formulation — Tatti 2012 is the correct DFU RCT to reference
26
The Arribaslopez et al. (2021) systematic review and meta-analysis in Nutrients journal analysed how many human studies on Arginine and Glutamine supplementation in wound healing?
A
12 studies across 4 databases
B
28 studies across 6 databases
C
44 human studies across 10 databases
D
67 studies across 12 databases
27
Kisil & Gimelfarb (2023, J Yeungnam Medical Science) — the most recently published study supporting the formulation class — showed which specific outcome for pressure ulcer patients?
A
140-day median healing (HMB/Arg/Gln) vs 200-day (SOC) — p<0.03
B
170-day median healing (HMB/Arg/Gln) vs 218-day (SOC alone) — p<0.046
C
120-day median healing (HMB/Arg/Gln) vs 180-day (SOC alone) — p<0.05
D
180-day median healing (HMB/Arg/Gln) vs 280-day (SOC alone) — p=0.02
28
The India study showed a 39% relative improvement in healing rate. This figure is calculated as:
A
72.4% − 52.1% = 20.3 percentage points (the absolute difference)
B
(72.4 − 52.1) ÷ 52.1 × 100 = 39% — relative improvement over control arm's performance
C
72.4 ÷ 52.1 = 1.39, meaning Epithrive® patients healed 39 times faster
D
100 − 72.4 = 27.6% remaining wound area, which is 39% less than the control arm's 52.1%
🎯
Section 5
Sales Skills
Questions 29–33 · 5 marks
29
In the PRECBAC call structure, the "E" step (Explore) must occur at which point in the call — and why?
A
After evidence delivery — to check if the doctor has questions about the study
B
Before pitching — needs assessment first ensures the pitch is calibrated to the doctor's specific challenge, not delivered generically
C
After rapport building — to establish the relationship before asking clinical questions
D
During the close — to understand if the doctor needs more information before committing
30
Which closing statement represents best practice for a first call on an Orthopaedic Surgeon?
A
"Please recommend Epithrive® to all your wound patients whenever appropriate."
B
"Would you add Epithrive® to your hospital formulary this month?"
C
"Would you try Epithrive® on your next DFU patient whose wound hasn't shown 30% improvement in 4 weeks and whose albumin is below 3.5 g/dL?"
D
"Can I email you the full clinical dossier for your review?"
31
A doctor says "My patients already take Ensure — they don't need another supplement." The most effective response strategy is:
A
Explain that Ensure is inferior and Epithrive® should replace it
B
Agree that Ensure is good for general nutrition, then explain that Epithrive® adds the wound-specific substrates (7g Arginine, 7g Glutamine, HMB, Marine Collagen) that are absent in Ensure — positioning them as complementary
C
Show a side-by-side comparison table demonstrating that Ensure has no clinical evidence
D
Explain that Epithrive® is significantly cheaper than Ensure per serving
32
In the doctor prioritisation matrix, a surgeon who has high wound patient volume but low receptiveness to new products belongs in which quadrant — and what is the correct engagement strategy?
A
Top Priority — weekly visits and maximum investment to convert quickly
B
Low Priority — minimal time investment; wait for them to become receptive naturally
C
Long Game — bi-weekly visits with different clinical angles; find alternate entry through nurse or dietitian
D
Ignore this doctor type — high volume low receptiveness doctors never convert
33
What is the optimal timing and content for a WhatsApp follow-up message after a first doctor call?
A
Within 5 days; send all available Epithrive® materials in a single message
B
Within 24 hours; reference the specific conversation and attach one company-approved PDF relevant to their specialty; include the mandatory disclaimer
C
Only when the doctor messages first to show interest
D
At the same time each week regardless of when the call occurred; consistency builds familiarity
⚖️
Section 6
Compliance & Regulatory
Questions 34–38 · 5 marks
34
Which of the following is a fully compliant statement that an Epithrive® MR may make during a doctor call?
A
"Epithrive® is clinically proven to heal diabetic foot ulcers and pressure sores."
B
"This is an FSMP — a Food for Special Medical Purposes, specifically approved for wound patients."
C
"In our clinical study (CSR-ETH-2025-001), the Epithrive® arm showed 72.4% wound area reduction versus 52.1% with standard care alone at Week 8 — p=0.004."
D
"Epithrive® guarantees measurable wound improvement within 2 weeks for most patients."
35
Epithrive® is currently classified under which regulatory category in India — and what is the implication for what an MR may claim?
A
FSMP (Food for Special Medical Purposes) — may make condition-specific nutritional management claims
B
Schedule H drug requiring prescription — full disease treatment claims are permitted
C
Nutraceutical/Dietary Supplement under FSSAI (Licence 11524998000214) — nutrient function and adjunct support claims are permitted; disease treatment claims are prohibited
D
OTC general medicine approved by CDSCO — disease treatment claims are permitted with appropriate scientific substantiation
36
A patient's family member contacts you reporting difficulty breathing and facial swelling within 1 hour of taking the first Epithrive® sachet. What is your immediate and complete response?
A
Reassure them it is the Arginine causing vasodilation — normal, transient, no action needed
B
Tell them to reduce to half a sachet and monitor for the next 24 hours before deciding to stop
C
Note it for the monthly adverse event report; these symptoms are common and self-limiting
D
Advise stopping Epithrive® immediately, seek emergency medical attention, document all details (dose, timing, symptoms, batch number), and escalate to Area Manager within the hour
37
The mandatory disclaimer that must accompany any Epithrive® outcome claim in any communication channel is:
A
"Results may vary. Individual outcomes are not guaranteed. Consult your physician."
B
"FSSAI registered product. Clinical evidence available on request."
C
"Dietary supplement. Not intended to diagnose, treat, cure, or prevent any disease. For nutritional support as an adjunct to standard wound care."
D
"This nutraceutical has not been evaluated by CDSCO as a drug. For dietary use only."
38
A doctor, impressed with Epithrive®, enthusiastically asks you to write "Proven to heal chronic wounds" on the patient information sheet you're leaving behind. What is the correct response?
A
Write it — the doctor's clinical authority provides sufficient justification for this phrasing
B
Write it in pencil so it can be erased if needed; the doctor's enthusiasm is a positive signal
C
Decline politely, explain the regulatory constraint (nutraceutical — disease treatment claims are prohibited), offer compliant alternative language, and pass the feedback to management
D
Call your Area Manager and write it if they approve over the phone
🚀
Section 7
Field Application
Questions 39–40 · 2 marks
39
A General Surgeon tells you: "We tried Epithrive® on a patient last month with a deep surgical site infection — it didn't work." The correct first response is:
A
Immediately present the India clinical study data showing 72.4% wound area reduction to counter the negative experience
B
Apologise and offer a free product replacement for the patient who didn't respond
C
"Thank you for telling me — can I ask what the wound status was at the time Epithrive® was started? Was active infection present?" — to investigate the patient selection context
D
Report this as an adverse event immediately and escalate to Medical Affairs
40
During a third call, an ICU physician says "I'd like to formally add Epithrive® to our ICU nutrition protocol." What is the ideal next step an MR should propose?
A
Thank the doctor and confirm the hospital pharmacy will begin stocking it automatically
B
Offer to prepare a one-page institutional protocol addition document with dosing, patient selection criteria, drug spacing notes, and clinical evidence — and schedule a joint meeting with the physician and clinical dietitian
C
Immediately forward the request to the hospital's procurement department without further involvement
D
Ask the doctor to submit a formal written request to the nutrition committee independently
Ensure all 40 questions are answered before submitting. Unanswered questions are marked incorrect.
Examination Review
Correct answers highlighted in green · Your wrong answers in red